Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...

Benefit claimants, whistleblowers and welfare experts working on the frontline offer Labour ministers alternatives to cuts ...

WHEN life gave Lina Nielsen lemons, she sprinted straight to the Olympics.  The 28-year-old was diagnosed with multiple sclerosis at 17 years old, leaving her terrified of disability. Doctors gave ...

"With no treatment options currently available for the broad population of patients with secondary progressive multiple sclerosis, tolebrutinib has demonstrated its ability to delay disability by ...

the company has said it will press ahead with a regulatory filing after a third study in non-relapsing secondary progressive MS was positive. Sanofi said that the two relapsing studies – GEMINI ...

Not many teachers can say they’ve taught almost every student while walking down the halls of a seventh through twelfth-grade ...

KBC Group NV boosted its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 48.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned ...

To demolish high-rise buildings, engineers often opt for 'top down' techniques, whereby a number of small, car-sized ...

The screening and consulting of each student will take about 30 minutes, with trained nurses and lifestyle coaches reviewing ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...